Guzal E Kangilbaeva

Dr. Guzal E Kangilbaeva

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Data in Brief
Verified
Journal Article
Open access
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
FBFazilat Bakhritdinova
Fazilat Bakhritdinova
INIroda Nabieva
Iroda Nabieva
AJAziza Jurabekova
Aziza Jurabekova
This paper presents a data from examinations of patients treated in clinic of Tashkent medical academy, Uzbekistan. 165 Patients (305 eyes) with NPDR were randomly allocated to receive standard treatment as the control group, in addition to the standard treatment daily tablets of EGb 761 (Tanakan, Beaufour Ipsen Industrie, Paris, France) 120 mg as the 1st main group, or daily endonasal electrophoresis of Tanakan 40 mg as 2nd main group, within 10 days. All of the patients underwent baseline ophthalmologic examinations, definition of biochemical parameters of the lacrimal fluid and Doppler ultrasound imaging of the eye. Moreover, correlation between tear fluid and hemodynamics was calculated. This data is essential for researchers to develop diagnostic criteria for diabetic retinopathy stages. Data are also beneficial to practitioners in determining the diabetic retinopathy severity and choosing appropriate treatment.

2 January 2023 in Ophthalmology Research: An International Journal
Verified
Journal Article
Closed access
PDF file
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
FBFazilat Bakhritdinova
Fazilat Bakhritdinova
BOBehruz Oralov
Behruz Oralov
AJAziza Jurabekova
Aziza Jurabekova
Aims: To study the effectiveness of the treatment of patients with non-proliferative diabetic retinopathy by tanakan endonasal electrophoresis according to functional and hemodynamic data. Study Design: Cross-sectional comparative analysis. Place and Duration of Study: Department of Ophthalmology, clinic of Tashkent Medical Academy, between 2017 and 2020. Methodology: We included 66 patients (123 eyes), 23 men and 43 women; age range 18-75 years with non-proliferative diabetic retinopathy. The patients were divided into 2 groups: to receive daily tablets of Tanakan (control), or daily endonasal electrophoresis of Tanakan (main) within ten days. Before and after the course of therapy, the patients underwent determination of visual acuity, Doppler ultrasound imaging of the eye and computer static perimetry. Results: Improvements in visual acuity were observed in 87,3% of the main group patients, and in 22% of the control group. Statistically significant increase in blood flow velocity and a decrease in the resistance index were observed in the main group (P < 0.05). Retinal photosensitivity increased by 22% in the main group, and by 10% in the control group. The mean deviation from the age norm decreased by 33% in the main group and by 12% in the control group. Among the patients of the main group, 30% experienced a decrease in absolute scotomas and 100% in relative scotomas. Among the patients of the control group, 21% and 83% experienced a decrease in absolute and relative scotomas, respectively. Conclusion: Treatment with tanakan endonasal electrophoresis significantly improved visual acuity, eye hemodynamics, and retinal photosensitivity. This treatment is more effective than the traditional use of ginkgo- biloba tablets.

22 February 2023 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
ФУФ. М Урманова
Ф. М Урманова
ФБФ. А. Бахритдинова
Ф. А. Бахритдинова
ААА. А. Ахраров
А. А. Ахраров
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
Relevance. Despite modern advances in medicine, type 2 diabetes mellitus (DM 2) still remains an important medical and social problem due to the frequency and severity of complications. The purpose of our study. The aim of the study was to evaluate the relationship between the levels of vascular growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) in blood serum and the area of the foveal avascular zone (FAZ) on OCT-A in patients with type 2 diabetes mellitus (DM2), with various stages DR. Materials and methods. A clinical study was conducted among 252 people (n=504), of which 168 patients with type 2 diabetes and 84 practically healthy individuals, the average age of which was 57.6 ± 7.8 years, of which 52.6% were men, 47.4% women. Results. As a result of the studies, an increase in the level of VEGF in the blood serum before the onset of DR clinically was revealed 137.2 ± 84.4 pg/ml (group II of comparison). It was found that the level of VEGF correlated with the levels of BDNF in the serum of patients and with the stage of retinopathy (p<0.05). Based on the studies performed, it was suggested that a mild deficiency with plasma BDNF less than 0.62 ng/ml indicates DR in general, and a BDNF level < 0.22 ng/ml indicates the development of PDR and/or diabetic macular ischemia (DME). Thus, a low level of BDNF and a high level of VEGF in serum can be potential risk factors for DR in T2 DM and serve as its diagnostic indicators.

22 February 2023 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
ФБФ. А. Бахритдинова
Ф. А. Бахритдинова
ФУФ. М. Урманова
Ф. М. Урманова
Relevance. The aim of this study was to determine the correlation of indicators of nitric oxide and oxidative stress of the lacrimal fluid with the severity of non-proliferative diabetic retinopathy. Materials and methods. Clinical studies were conducted during the treatment of 36 patients (69 eyes) diagnosed with non-proliferative diabetic retinopathy (NDR). Patients underwent a general ophthalmological examination and biochemical studies of the lacrimal fluid. Results. Studies have shown a gradual decrease in nitric oxide levels as DR worsens. In patients with NDR 1a severity, the level of nitric oxide decreased statistically significantly by 22.3% (P<0.001), and in 1c severity this level decreased by 66.7% (P<0.001) relative to the values of practically healthy individuals and by 57.1% (P<0.001) compared with the indices of patients with 1a NDR severity. Conclusion. The severity of NDR is directly related to the level of nitric oxide in the lacrimal fluid of patients: as the content of nitric oxide decreases, progression of retinopathy is observed. The imbalance in the POL-AOS system has a staged character.

24 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
FBFazilat Bakhritdinova
Fazilat Bakhritdinova
AJAziza Jurabekova
Aziza Jurabekova
Purpose: The aim of this study was to explore the evolution of automated diagnosis of diabetic retinopathy from visualization and automatic segmentation of the ocular fundus imaging to the diagnosis of stages of diabetic retinopathy by deep learning algorithms in artificial intelligence programs. Methods. Search published works in PubMed, ScienceDirect and similar search engines, from 2006 to 2023, using a combination of keywords in the medical field (ophthalmology, diabetic retinopathy, screening) and machine learning (artificial intelligence, deep learning, neural connection) has allowed us to identify the 160 publications we’ve analyzed. The article is formed by the consistent analysis of various computer programs as their complexity. Results: Artificial intelligence programs, rapidly developing in recent years, are successfully used to diagnose vision-threatening diabetic retinopathy. Artificial intelligence programs have demonstrated sensitivity ranging from 82-99.1% and specificity ranging from 63-90% in detecting vision-threatening diabetic retinopathy. Conclusion: Artificial intelligence programs will undoubtedly help doctors timely diagnose vision-threatening diabetic retinopathy. AI-enabled screening programs will help reach hard-to-reach, densely populated, low-income areas. The authors hope that similar programs that use artificial intelligence to diagnose diabetic retinopathy will become widely available throughout the world.